Bristol-Myers Squibb Company
US ˙ NYSE ˙ US1101221083

SecurityBMY / Bristol-Myers Squibb Company
InstitutionWELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2
Latest Disclosed Ownership1,599 shares
Latest Disclosed Value $ 74,017
WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 reports 4.14% decrease in ownership of BMY / Bristol-Myers Squibb Company

On August 26, 2025 - WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 filed a NPORT-P form disclosing ownership of 1,599 shares of Bristol-Myers Squibb Company (US:BMY) valued at $74,018 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 1,668 shares of Bristol-Myers Squibb Company. This represents a change in shares of -4.14% during the quarter. The current value of the position is $91,575 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Bristol-Myers Squibb EC US1101221083 1,599 -69 -4.14 74 -26.73 0.1090
2025-05-27 2025-03-31 NP Bristol-Myers Squibb EC US1101221083 1,668 -53 -3.08 102 4.12 0.1533
2025-02-26 2024-12-31 NP Bristol-Myers Squibb EC US1101221083 1,721 -110 -6.01 97 3.19 0.1393
2024-11-25 2024-09-30 NP Bristol-Myers Squibb EC US1101221083 1,831 -49 -2.61 95 20.51 0.1306
2024-08-26 2024-06-30 NP Bristol-Myers Squibb EC US1101221083 1,880 -52 -2.69 78 -25.00 0.1118
2024-05-28 2024-03-31 NP Bristol-Myers Squibb EC US1101221083 1,932 -104 -5.11 105 0.00 0.1502
2024-02-28 2023-12-31 NP Bristol-Myers Squibb EC US1101221083 2,036 -105 -4.90 104 -16.13 0.1566
2023-11-22 2023-09-30 NP Bristol-Myers Squibb EC US1101221083 2,141 -259 -10.79 124 -18.95 0.1999
2023-08-28 2023-06-30 NP Bristol-Myers Squibb EC US1101221083 2,400 -18 -0.74 153 -8.38 0.2315
2023-05-25 2023-03-31 NP Bristol-Myers Squibb EC US1101221083 2,418 -49 -1.99 168 -5.65 0.2599
2023-02-24 2022-12-31 NP Bristol-Myers Squibb EC US1101221083 2,467 -56 -2.22 178 -1.12 0.2837
2022-11-29 2022-09-30 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 2,523 -56 -2.17 179 -9.60 0.2926
2022-08-29 2022-06-30 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 2,579 -117 -4.34 199 1.02 0.3023
2022-05-31 2022-03-31 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 2,696 -127 -4.50 197 11.36 0.2577
2022-02-28 2021-12-31 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 2,823 -105 -3.59 176 1.73 0.2117
2021-11-24 2021-09-30 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 2,928 -144 -4.69 173 -15.61 0.2153
2021-08-27 2021-06-30 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 3,072 -176 -5.42 205 0.00 0.2504
2021-06-01 2021-03-31 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 3,248 -213 -6.15 205 -4.21 0.2585
2021-03-01 2020-12-31 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 3,461 -206 -5.62 215 -3.17 0.2724
2020-11-25 2020-09-30 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 3,667 -159 -4.16 221 -1.34 0.2967
2020-08-28 2020-06-30 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 3,826 52 1.38 225 6.67 0.3159
2020-05-28 2020-03-31 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 3,774 -83 -2.15 210 -14.98 0.3292
2020-02-28 2019-12-31 NP BRISTOL MYERS SQUIBB CO USD.1 EC 110122108 3,857 996 34.81 248 70.34 0.3427
2019-11-26 2019-09-30 NP BRISTOL MYERS SQUIBB CO USD.1 EC US1101221083 2,861 2,861 145 0.2009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.